Please ensure Javascript is enabled for purposes of website accessibility

CVS Health Just Beat Expectations and Raised Some

By Cory Renauer – Feb 12, 2020 at 11:52AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The growing healthcare conglomerate outperformed forecasts in the fourth quarter, and boosted its outlook for the year ahead.

Shares of CVS Health (CVS -1.66%) ticked up on Wednesday morning after the company reported fourth-quarter earnings that exceeded Wall Street expectations and management's own targets.

The first year following its acquisition of Aetna was a good one for the company, and 2020 could be even better. The growing healthcare conglomerate raised its guidance for 2020 from the levels it set in June. 

Pharmacist at work.

Image source: Getty Images.

In the numbers 

During the fourth quarter, CVS Health reported $66.9 billion in total revenue, $2.9 billion more than analysts' consensus estimate. On the bottom line, adjusted earnings per share reached $1.73, which was $0.04 higher than the analysts' average prediction.

CVS Health's pharmacy benefits management business processed 10.2% more claims than during the prior-year period, but generic drug pricing pressure limited its revenue growth to 6.2%. CVS Health's retail segment processed 5.6% more prescriptions, but reimbursement pressure held revenue growth to 2.5%.

The health insurance operation that CVS Health acquired from Aetna had 22.9 million members in the fourth quarter, but it produced just 21% of total operating income that rose 1.3% to $3.8 billion during the period. The amount spent providing care worked out to 85.7% of premiums collected, which is pretty good, but not as impressive as the 82.6% medical benefit ratio that UnitedHealth Group recorded during the fourth quarter.

CVS Health's plan to leverage its colossal retail footprint will accelerate in 2020. The company expects to have between 600 and 650 HealthHUB locations that allow patients to manage chronic diseases, fill prescriptions, and do a little shopping before quickly getting on with their lives.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health and UnitedHealth Group. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
$95.37 (-1.66%) $-1.61
UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
$505.04 (-0.74%) $-3.79

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.